D'Haese P C, De Broe M E
Department of Nephrology-Hypertension, University of Antwerp, Belgium.
Nephrol Dial Transplant. 1996;11 Suppl 2:92-7. doi: 10.1093/ndt/11.supp2.92.
A number of considerations suggest that trace element disturbances might occur in dialysed patients. These must at least in part be ascribed to the dialysis treatment itself during which these constituents may either be transferred to or removed from the patient. Tap water must be considered as the main source of dialysate trace metal contamination. These can adequately be removed during water treatment provided that, in addition to softening and deionization, reverse osmosis is available. However, even in the presence of the latter devices the possibility of serious contamination of the dialysis fluids leading to either chronic or acute intoxications still exists. The addition of chemical concentrates may also contribute to the increased concentrations of a number of trace metals. The toxic effects of aluminium in dialysis patients are well known and at the present time the element is still responsible for the greater part of trace metal-related problems in dialysis patients. Hence, the need for regular monitoring of aluminium cannot be ruled out at present. Strategies for diagnosis and treatment of aluminium overload have been updated. Recent studies demonstrated the efficacy of low desferrioxamine doses in diagnosis and treatment of aluminium overload, and optimal schedules for administration of the chelator and duration of treatment have been presented. Recently, in an epidemiological survey serum silicon concentrations in dialysis patients were found to be increased up to 100-fold compared to subjects with normal renal function. Moreover, it was noted that silicon concentrations in the dialysis population differ from one centre to another and that increased levels are due to either the use of silicon-contaminated dialysis fluids or an increased oral intake of the element originating from a high silicon content in the drinking water. Besides aluminium and silicon, a transfer towards the patients during dialysis has also been reported for a number of other elements including copper, zinc, nickel, strontium and chromium. The possible consequences of dialysate contamination with these elements will briefly be dealt with in the present paper. In contrast to trace metal accumulation, removal of trace metals during dialysis may at least in part contribute to the relative deficiency of particular essential elements. Selenium deficiency has repeatedly been observed. In view of the element's well-known essential role in glutathion peroxidase activity and the association of its deficiency with the development of some malignant diseases, further studies on the clinical impact of decreased serum selenium in dialysis patients are worthwhile. In conclusion, trace metal dialysate contamination/ depletion may contribute to the disturbed trace element concentration in dialysis patients. Aluminium accumulation is still an important problem in clinical nephrology. The clinical importance of the accumulation/ deficiency of trace elements other than aluminium is not yet fully understood and deserves further investigation.
一些因素表明,透析患者可能会出现微量元素紊乱。这些紊乱至少部分归因于透析治疗本身,在此过程中这些成分可能会转移到患者体内或从患者体内清除。自来水必须被视为透析液微量金属污染的主要来源。只要在软化和去离子化之外还能进行反渗透,这些污染物就能在水处理过程中被充分去除。然而,即使有了后者这些设备,透析液严重污染导致慢性或急性中毒的可能性仍然存在。添加化学浓缩物也可能导致多种微量金属浓度增加。铝对透析患者的毒性作用是众所周知的,目前该元素仍然是透析患者中与微量金属相关问题的主要原因。因此,目前不能排除定期监测铝的必要性。铝过载的诊断和治疗策略已经更新。最近的研究证明了低剂量去铁胺在铝过载诊断和治疗中的有效性,并提出了螯合剂的最佳给药方案和治疗持续时间。最近,在一项流行病学调查中发现,与肾功能正常的受试者相比,透析患者的血清硅浓度增加了100倍。此外,还注意到透析人群中的硅浓度因中心而异,浓度升高是由于使用了受硅污染的透析液或因饮用水中高硅含量导致元素口服摄入量增加。除了铝和硅之外,透析过程中还有多种其他元素也被报告转移到了患者体内,包括铜、锌、镍、锶和铬。本文将简要探讨透析液被这些元素污染可能产生的后果。与微量金属积累相反,透析过程中微量金属的清除可能至少部分导致特定必需元素的相对缺乏。硒缺乏已多次被观察到。鉴于该元素在谷胱甘肽过氧化物酶活性中众所周知的重要作用及其缺乏与某些恶性疾病发生的关联,进一步研究透析患者血清硒降低的临床影响是值得的。总之,透析液微量金属污染/消耗可能导致透析患者微量元素浓度紊乱。铝蓄积仍然是临床肾脏病学中的一个重要问题。除铝之外的微量元素蓄积/缺乏的临床重要性尚未完全了解,值得进一步研究。